Response to comment on "Community-wide isoniazid preventive therapy drives drug-resistant tuberculosis: a model-based analysis".

Abstract	Our modeling work suggests that isoniazid preventive therapy (IPT) can be effective in reducing drug-sensitive tuberculosis (TB) and that the risk of IPT driving resistance can be reduced by improving the detection and rapid treatment of individuals with drug-resistant disease and by limiting IPT to those in whom the intervention will have the largest benefit.
Authors	Harriet L Mills, Ted Cohen, Caroline Colijn
Journal	Science translational medicine (Sci Transl Med) Vol. 5 Issue 204 Pg. 204lr4 (Sep 25 2013) ISSN: 1946-6242 [Electronic] United States
PMID	24068734 (Publication Type: Letter, Comment)
Chemical References	Antitubercular Agents Isoniazid
Topics	Antitubercular Agents (therapeutic use) Humans Isoniazid (therapeutic use) Tuberculosis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!